Short description
Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.
Description
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Hayward, California, United States, North America
Founded on
January 1, 1991
Exited on
June 28, 1996
Went public on
June 28, 1996
Stock symbol
ARDM
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Nopepepe, Uh Ohhhh, Noaccessforu, Uh Ohhhh
Sign in for full access
Founders
Reid Rubsamen